2021
DOI: 10.1016/j.jcct.2020.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Myocardial injury in COVID-19: The role of coronary computed tomography angiography (CTA)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0
2

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 3 publications
0
13
0
2
Order By: Relevance
“…(1) Acute coronary syndrome (ACS) due to either cytokine mediated plaque instability or inflammatory prothrombotic stage; 91 2) Myocardial mismatch between myocardial demand and consumption of oxygen leading to type 2 myocardial infarction; [92][93][94] (3) Direct cardiac damage mediated by the membrane protein angiotensin converting enzyme 2; 95 (4) Inflammatory myocarditis due to the massive release of interleukin-1 and interluking-6, occurring in the advanced stage of the disease. 96 Due to this complex scenario and due to the overlapping of clinical presentation, interpretation of elevated troponin may be extremely challenging.…”
Section: Role Of Cardiac Ct In Covid-19 Patients With Myocardial Injurymentioning
confidence: 99%
See 2 more Smart Citations
“…(1) Acute coronary syndrome (ACS) due to either cytokine mediated plaque instability or inflammatory prothrombotic stage; 91 2) Myocardial mismatch between myocardial demand and consumption of oxygen leading to type 2 myocardial infarction; [92][93][94] (3) Direct cardiac damage mediated by the membrane protein angiotensin converting enzyme 2; 95 (4) Inflammatory myocarditis due to the massive release of interleukin-1 and interluking-6, occurring in the advanced stage of the disease. 96 Due to this complex scenario and due to the overlapping of clinical presentation, interpretation of elevated troponin may be extremely challenging.…”
Section: Role Of Cardiac Ct In Covid-19 Patients With Myocardial Injurymentioning
confidence: 99%
“… 2 , 65 , 66 , 87 , 88 , 89 Of note, patients with elevated cardiac troponin were proved at increased risk of morbidity and mortality compared to patients who did not developed cardiac injury. 89 The causes leading to myocardial injury in COVID-19 are multiple 90 and they can be summarised as follows: Acute coronary syndrome (ACS) due to either cytokine mediated plaque instability or inflammatory prothrombotic stage; 91 Myocardial mismatch between myocardial demand and consumption of oxygen leading to type 2 myocardial infarction; 92 , 93 , 94 Direct cardiac damage mediated by the membrane protein angiotensin converting enzyme 2; 95 Inflammatory myocarditis due to the massive release of interleukin-1 and interluking-6, occurring in the advanced stage of the disease. 96 …”
Section: Role Of Cardiac Ct In Covid-19 Patients With Myocardial Injumentioning
confidence: 99%
See 1 more Smart Citation
“…Acute coronary syndromes with normal or near-normal coronary arteries (ACS-NNOCA), comprising MI with nonobstructive coronary arteries (MINOCA) or MI with normal coronary arteries (MINCA) and ischemic syndromes with non-obstructive coronaries (INOCA), 10 are being increasingly reported in patients with COVID-19 infection (Table 2). [64][65][66] In a case series of 18 COVID-19 patients presenting with STEMI, 3 of 9 (33%) patients undergoing coronary angiography did not have obstructive coronary artery disease (CAD). 67 In an observational study of 118 consecutive confirmed COVID-19 patients (median age 66 years, all men) undergoing transthoracic echocardiography, 5 (4.2%) patients had features compatible with TTC; however, these patients had no coronary angiography to exclude CAD.…”
Section: Acute Coronary Syndromes With Normal or Near-normal Coronariesmentioning
confidence: 99%
“…74 A recent case report described a COVID-19 patient who presented with MINOCA (NSTEMI) and CTCA showed signs of vasculitis with diffuse wall irregularities and focal thickening, which was considered to have triggered endothelial dysfunction and vasospasm. 65 A prospective study enrolled all STEMI patients who underwent primary PCI during the COVID-19 period (83 patients) and compared them with a previous cohort of STEMI patients (2008-2017, n ¼ 1,552 patients); non-COVID-19 patients (n ¼ 72) were also compared with COVID-19 patients (n ¼ 11). 66 Patients during the outbreak period were older, significantly delayed seeking care and sustained a two-fold higher inhospital mortality.…”
Section: Acute Coronary Syndromes With Normal or Near-normal Coronariesmentioning
confidence: 99%